Predicting the Progression of Autoimmune Disease with AI
Knowing who may progress along the disease pathway is critical for early diagnosis and intervention, improved treatment and better disease management,
Knowing who may progress along the disease pathway is critical for early diagnosis and intervention, improved treatment and better disease management,
The artificial intelligence–based model, dubbed SCORPIO, was developed by a team of researchers from Memorial Sloan Kettering Cancer Center (MSK) and the Tisch Cancer Institute at Mount Sinai.